NANOBIOTIX (EPA:NANO) | Finanzwire

Basculer en Français

10482	Companies
220830	Keywords
150169	Articles
116820	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 05/26/2026 at 23:04, 6 days 2 hours ago

NANOBIOTIX Completes Global Offering with $100 Million Proceeds

Securities Biotechnology Investment Global Offering NANOBIOTIX
PRESS RELEASE

published on 05/26/2026 at 22:59, 6 days 2 hours ago

NANOBIOTIX Announces Closing of Global Offering
Nanobiotix closes global offering with total gross proceeds of $100 million. Proceeds to fund development and corporate purposes. Ordinary shares and ADSs issued

Development ADSs Proceeds Global Offering NANOBIOTIX
BRIEF

published on 05/22/2026 at 22:20, 10 days 3 hours ago

NANOBIOTIX raises $100 million through a global offering

Biotechnology Fundraising Ads Cancer NANOBIOTIX
PRESS RELEASE

published on 05/22/2026 at 22:15, 10 days 3 hours ago

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
Nanobiotix fully exercises underwriters' over-allotment option, raising gross proceeds of approximately $100 million from global offering. Proceeds allocated for development and general corporate purposes

Development Underwriters Proceeds Global Offering NANOBIOTIX
BRIEF

published on 05/21/2026 at 15:35, 11 days 10 hours ago

Nanobiotix resumes its negotiations on Euronext Paris

Euronext Paris Biotechnology Qualified Investors NANOBIOTIX ADS Offer
BRIEF

published on 05/21/2026 at 15:35, 11 days 10 hours ago

Nanobiotix Resumes Trading of Ordinary Shares on Euronext Paris

Euronext Paris Biotechnology Trading Resumption Global Offering NANOBIOTIX
PRESS RELEASE

published on 05/21/2026 at 15:30, 11 days 10 hours ago

Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
Nanobiotix announces trading resumption of its ordinary shares on Euronext Paris following Global Offering. Company pioneers physics-based approaches to expand cancer treatment possibilities

Euronext Paris Cancer Treatment Trading Resumption Global Offering NANOBIOTIX
BRIEF

published on 05/21/2026 at 08:35, 11 days 17 hours ago

Temporary suspension of Nanobiotix shares on Euronext Paris

Euronext Paris Actions Suspension NANOBIOTIX Global Offer
PRESS RELEASE

published on 05/21/2026 at 08:30, 11 days 17 hours ago

Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
Nanobiotix announces temporary trading halt of its ordinary shares on Euronext Paris for Global Offering pricing and allocation confirmation

Euronext Paris Trading Halt Pricing Global Offering NANOBIOTIX
BRIEF

published on 05/21/2026 at 00:24, 12 days 1 hour ago

Nanobiotix Launches Global Follow-On Offering

Biotechnology ADSs Global Offering NANOBIOTIX Biopharmaceutical Investment

Accesswire

Published on 06/02/2026 at 00:00, 1 hour 40 minutes ago

Boron One Announces Financing
Published on 06/01/2026 at 23:57, 1 hour 43 minutes ago

Metallic Minerals Announces Bought Deal LIFE Private Placement for Gross Proceeds of C$8.0 Million
Published on 06/01/2026 at 23:05, 2 hours 35 minutes ago

Faraday Copper Strengthens Team to Support Project Advancement in Arizona
Published on 06/01/2026 at 23:00, 2 hours 40 minutes ago

CCL Industries Closing of Sleever International Acquisition
Published on 06/01/2026 at 22:30, 3 hours 10 minutes ago

Revolve to Present at the Small Cap Growth Virtual Investor Conference on June 4, 2026

View all ACCESSWIRE

EQS Group

Published on 06/01/2026 at 23:00, 2 hours 40 minutes ago

DriveNets Secures $410M Series D to Meet Surging Demand for Ethernet Fabric in Large-Scale AI Deployments
Published on 06/01/2026 at 22:05, 3 hours 35 minutes ago

EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Published on 06/01/2026 at 22:05, 3 hours 35 minutes ago

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
Published on 06/01/2026 at 21:20, 4 hours 20 minutes ago

Eurobattery Minerals: Loft Capital exercises conversion rights – Conversion Threshold Date reached and a total of 23,798,419 new shares to be registered
Published on 06/01/2026 at 19:00, 6 hours 40 minutes ago

Armen Pogossian Represents Armenia at Forbes Under 30 Summit China, Empowering the Next Generation of Global Entrepreneurs

Les Echos

Published on 06/01/2026 at 18:47, 6 hours 53 minutes ago

Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 7 hours 40 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 06/01/2026 at 17:54, 7 hours 46 minutes ago

Reporting on share buyback transactions carried out on May 28, 2026
Published on 06/01/2026 at 17:54, 7 hours 46 minutes ago

TF1 - Monthly disclosure of the total number of shares and voting rights - May 2026
Published on 06/01/2026 at 17:45, 7 hours 55 minutes ago

ENGIE secures €1 billion export financing backed by Euler Hermes

View all LES ECHOS COMFI WIRE